For citations:
Plavinskiy S.L., Shabalkin P.I., Karelov A.E. PHARMACOECONOMIC ANALYSIS OF THE IMPACT ON THE BUDGET COSTS OF ADDING DEXMEDETOMIDINE (DEXDOR) INTO THE LIST OF VITAL AND ESSENTIAL DRUGS. Messenger of ANESTHESIOLOGY AND RESUSCITATION. 2015;12(6):32-39. (In Russ.) https://doi.org/10.21292/2078-5658-2015-12-6-32-39
Email this article 